Skip to content
Biotechnology, Medical Health Aged Care

AI with a heart: Neural network predicts survival of critically ill patients on heart-lung bypass

Monash University 2 mins read

A research team led by engineers and cardiologists from Monash University has used artificial intelligence (AI) to develop an algorithm to accurately predict the survival of intensive care patients who need external heart-lung support (ECMO).

The ECMO Predictive Algorithm or “ECMO PAL” is the first AI-powered ECMO survival score trained and validated on a large international patient cohort.


The importance and groundbreaking nature of the research has been recognised by the Cardiac Society of Australia and New Zealand (CSANZ), which selected Monash researcher and cardiologist Dr Michael Šeman as a finalist for its prestigious Ralph Reader Prize for young investigators.


ECMO: Life-saving, complex but costly

Venoarterial extracorporeal membrane oxygenation (commonly known as ECMO), an artificial heart-lung system operated outside the body, is often used to support critically ill patients who have severe cardiac and respiratory failure.


ECMO can be life-saving but is also complex, high risk and costly, so appropriate evidence-based patient selection is crucial.


Led by biomedical engineer Dr Andrew Stephens, deputy director of the Monash Cardio-Respiratory Engineering And TEchnology laboratory (CREATElab), and Dr Michael Šeman, the multidisciplinary research team set out to develop an accurate and beneficial predictive measure to improve data-driven decisions about ECMO patient selection, management and resource allocation.


A deep neural network (DNN), which mimics the behaviour of human learning and can recognise patterns to identify and solve problems, was trained using data from more than 18,000 patients treated with ECMO in more than 400 centres across Europe, North America, Latin America, Africa and the Asia-Pacific region.


AI outperformed existing scores


The resulting AI-derived model, ECMO PAL, outperformed all existing, widely-used scores in terms of its ability to predict the outcomes of ECMO treatment, particularly the risk that the patient would die in hospital.


ECMO PAL proved highly reliable and generalisable across different geographic regions and was able to make accurate predictions across a very diverse group of patients. 

“Using AI offered us an advanced alternative to statistical methods for developing risk and survival scores,” explained Dr Stephens.


“AI can be applied to large and variable data sets, and it can help uncover patterns and interactions that might otherwise be missed by traditional statistical approaches.”

Because the predictive accuracy of AI models can change over time as clinical practices and patient populations evolve, the Monash researchers have designed the ECMO PAL system to continue to learn, so the algorithm can be updated and “fine-tuned” with new data and predictive variables as they become available.

ECMO PAL will be made available in the coming weeks for free, global and anonymous use via www.ecmo-pal.icu 

The paper published in the international journal Intensive Care Medicine  “ECMO PAL: Using Deep Neural Networks for Survival Prediction in Venoarterial Extracorporeal Membrane Oxygenation” is the report of a collaborative study by researchers from CREATELab and the ANZ Intensive Care Research Centre at Monash, together with The VIctorian Heart Hospital, The Alfred (Alfred Health), the Baker Heart and Diabetes Institute, the University of Michigan Medical Center and Columbia University Irving Medical Centre, New York.


For media enquiries please contact:


Dr Andrew Stephens

Deputy director, Monash Cardio-Respiratory Engineering and Technology Laboratory 

E: [email protected] 

T: +61 (0) 437 034 036


For more Monash media stories visit our
news and events site

For general media enquiries please contact:

Monash Media

E: [email protected]

T: +61 (0) 3 9903 4840

Media

More from this category

  • Medical Health Aged Care, Mental Health
  • 16/06/2025
  • 00:01
UNSW Sydney

Neuroscience Drives New Wellbeing App: ReNeuWell Launched by NeuRA and UNSW Sydney

SYDNEY, NSW – [EMBARGOED 00.01 16/06/2025] – Researchers from NeuRA and UNSW Sydney have launched a new app aimed at boosting the wellbeing and resilience of adults. This innovative mobile application, called ReNeuWell, shifts the focus from managing distress to actively promoting mental flourishing, offering a neuroscience-backed, personalized approach to mental health. Designed by Associate Professor Justine Gatt, Director of the Centre for Wellbeing, Resilience and Recovery at NeuRA and UNSW’s School of Psychology, ReNeuWell is underpinned by the COMPAS-W Wellbeing Scale. This validated tool assesses both subjective (hedonic – composure, positivity, life satisfaction) and psychological (eudaimonic – self-worth, mastery,…

  • Medical Health Aged Care
  • 15/06/2025
  • 07:46
Royal Australian College of GPs

Men’s Health Week: Funding for longer consults can make GPs one-stop shop for sexual health and HIV prevention

During Men’s Health Week 2025 the Royal Australian College of GPs (RACGP) is calling on the Federal Government to improve men’s sexual health by boosting investment in general practice care so specialist GPs can provide longer consultations. The College says more funding for longer consultations would improve access to important preventive care, such as pre-exposure prophylaxis (PrEP), – a highly effective daily or on-demand medication that prevents HIV transmission in 99% of cases. RACGP Specific Interests Sexual Health Medicine Chair Dr Sara Whitburn said practices can offer the most convenient access to PrEP for people at higher risk of HIV,…

  • Contains:
  • Medical Health Aged Care
  • 15/06/2025
  • 07:20
Royal Australian College of GPs

GPs ready to support ACT to act on ADHD election commitment

The Royal Australian College of GPs (RACGP) has welcomed work in the ACT to allow GPs to diagnose and prescribe for ADHD. ACT Labor committed to allowing GPs to diagnose ADHD in the 2024 election that returned the party to government for the seventh time. Since that election, the WA Government has committed to improving access for patients by supporting specialist GPs to diagnose and treat ADHD following long-term advocacy by the RACGP and Western Australian GPs. The NSW Government also announced changes to improve access and affordability through treatment by GPs in May. Patients in NSW are expected to…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.